Thromb Haemost 1994; 71(04): 499-506
DOI: 10.1055/s-0038-1642467
Review Article
Schattauer GmbH Stuttgart

Radiolabeled r-Hirudin as a Measure of Thrombin Activity at, or within, the Rabbit Aorta Wall In Vitro and In Vivo

Mark W C Hatton
The Department of Pathology, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada
,
Bonnie Ross-Ouellet
The Department of Pathology, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received: 10 November 1992

Accepted after resubmission: 03 December 1993

Publication Date:
06 July 2018 (online)

Summary

The behavior of 125I-labeled recombinant hirudin towards the uninjured and de-endothelialized rabbit aorta wall has been studied in vitro and in vivo to determine its usefulness as an indicator of thrombin activity associated with the aorta wall. Thrombin adsorbed to either sulfopropyl-Sephadex or heparin-Sepharose bound >95% of 125I-r-hirudin and the complex remained bound to the matrix. Binding of 125I-r-hirudin to the exposed aorta subendothelium (intima-media) in vitro was increased substantially if the tissue was pre-treated with thrombin; the quantity of l25I-r-hirudin bound to the de-endothelialized intima-media (i.e. balloon-injured in vitro) correlated positively with the quantity of bound 131I-thrombin (p <0.01). Aortas balloon-injured in vivo were measured for thrombin release from, and binding of 125I-r-hirudin to, the de-endothelialized intimal surface in vitro; 125I-r-hirudin binding correlated with the amount of active thrombin released (p <0.001). Uptake of 125I-r-hirudin by the aorta wall in vivo was proportional to the uptake of 131I-fibrinogen (as an indicator of thrombin activity) before and after balloon injury. After 30 min in the circulation, specific 125I-r-hirudin binding to the uninjured and de-endo- thelialized (at 1.5 h after injury) aorta wall was equivalent to 3.4 (± 2.5) and 25.6 (±18.1) fmol of thrombin/cm2 of intima-media, respectively. Possibly, only hirudin-accessible, glycosaminoglycan-bound thrombin is measured in this way.

 
  • References

  • 1 Markwardt F. Hirudin as an inhibitor of thrombin. Meth Enzymol 1970; XIX: 924-932
  • 2 Stone SR, Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry 1986; 25: 4622-4628
  • 3 Talbot M. Biology of recombinant hirudin (CGP 39393): A new prospect in the treatment of thrombosis. Semin Thrombos Hemostas 1989; 15: 293-301
  • 4 Hatton MWC, Moar SL. Comparison of the effects of heparin and hirudin on thrombin binding to the normal and the de-endothelialised rabbit aorta in vitro. Thromb Haemostas 1991; 66: 208-212
  • 5 Low DA, Cunningham DD. A novel method for measuring cell surface- bound thrombin. J Biol Chem 1982; 257: 850-858
  • 6 Hatton MWC, Moar SL, Richardson M. De-endothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface Correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium. Amer J Pathol 1989; 135: 499-508
  • 7 McNamara CA, Sarembock IJ, Gimple LW, Fenton JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-8
  • 8 Hatton MWC, Moar SL. A role for pericellular proteoglycan in the binding of thrombin or antithrombin III by the blood vessel endothelium? The effects of proteoglycan-degrading enzymes and glycosaminoglycan-binding proteins on 125I-thrombin binding by the rabbit thoracic aorta in vitro. Thromb Haemostas 1985; 53: 228-234
  • 9 Bar-Shavit R, Eldor A, Vlodavsky I. Binding of thrombin to subendotheli- al extracellular matrix Protection and expression of functional properties. J. Clin Invest 1989; 84: 1096-104
  • 10 Weitz JI, Hudoba M, Massel J, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin Ill-independent inhibitors. J. Clin Invest 1990; 86: 385-391
  • 11 Rubens F, Ross-Ouellet B, Dennie C, Coates G, Kinlough-Rathbone RL, Hatton MWC. Displacement of fibrin-bound thrombin by-r-hirudin precludes the use of 131I-r-hirudin to detect pulmonary emboli in the rabbit. Thromb Haemostas. 1993. (Submitted)
  • 12 Lundblad RL, Uhteg LC, Vogel CN, Kingdon HS, Mann KG. Preparation and partial characterisation of two forms of bovine thrombin. Biochem Biophys Res Commun 1975; 66: 482-489
  • 13 Hatton MWC, Berry LR, Regoeczi E. Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta. Thrombos Res 1978; 13: 655-670
  • 14 Hatton MWC. Studies on the coagulation enzyme from Agkistrodon rhodostoma venom Isolation and some properties of the enzyme. Biochem J 1973; 131: 799-807
  • 15 Straughn W, Wagner RH. A simple method for preparing fibrinogen. Thrombos Diath Haemorrh 1967; 16: 198-206
  • 16 Lawrie JS, Ross J, Kemp GC. Purification of fibrinogen and the separation of its degradation products in the presence of calcium ions. Biochem Soc Trans 1979; 7: 693-694
  • 17 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
  • 18 Hatton MWC, Moar SL, Richardson M. Enhanced binding of fibrinogen by the subendothelium after treatment of the de-endothelialized rabbit aorta with thrombin. J Lab Clin Med 1990; 115: 356-64
  • 19 Regoeczi E. Iodine-Labeled Plasma Proteins. CRC Press; Boca Raton: (; 1). 1984: 49-56
  • 20 Hatton MWC, Moar SL. Uptake and catabolism of 125I-thrombin by the rabbit thoracic aorta in vitro: Permeability of the endothelium intima-me-dial and adventitial layers. Thromb Haemostas 1984; 52: 105-111
  • 21 Hatton MWC, Moar SL, Richardson M. Behavior of plasminogen at the luminal surface of the normal and de-endothelialized rabbit aorta in vivo and in vitro. Blood 1988; 71: 1260-1267
  • 22 Pugatch EMJ, Saunders AM. A new technique for making Hautchen preparations of unfixed aortic endothelium. J Atheroscler Res 1968; 8: 735-738
  • 23 Aster RH, Jandl JH. Platelet sequestration in man: I Methods. J Clin Invest 1964; 43: 843-854
  • 24 Prince H. Blood volume of the pregnant rabbit. Quart J Exp Physiol 1982; 67: 87-95
  • 25 Fleck A. Computer models for metabolic studies on plasma proteins. Ann Clin Biochem 1985; 22: 33-49
  • 26 Low DA, Baker JB, Koonce WC, Cunningham DD. Released protease nexin regulates cellularbinding internalization and degradation of serine proteases. Proc Natl Acad Sci USA 1981; 78: 2340-2344
  • 27 Barnhart MI, Baechler CA. Endothelial cell physiology pertubations and responses. Semin Thrombos Haemostas 1978; 5: 50-86
  • 28 Richardson M, Hatton MWC, Moore S. The plasma proteases thrombin and plasmin degrade the proteoglycan of rabbit aorta segments in vitro: An inlegialed uliiashucluial and biochemical study. Clin Invest Med 1988; 11: 139-150
  • 29 Markwardt F, Hauptmann J, Nowak G, Kleben C, Walsmann P. Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb Haemostas 1982; 47: 226-229
  • 30 Kaiser B, Simon A, Markwardt F. Antithrombotic effects of recombinant hirudin in experimental angioplasty and intravascular thrombolysis. Thromb Haemostas 1990; 63: 44-47